Detalhe da pesquisa
1.
Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma.
Int J Mol Sci
; 24(3)2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768928
2.
Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.
Eur J Pharm Biopharm
; 194: 49-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029941
3.
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
J Exp Clin Cancer Res
; 42(1): 293, 2023 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924157